Yuan Y, Tang Y, Fang Z, Wen J, Wicha M, Luo M
Cells. 2025; 14(3).
PMID: 39937018
PMC: 11817775.
DOI: 10.3390/cells14030227.
Zuo Y, Xue J, Wen H, Zhan L, Chen M, Sun W
Commun Biol. 2025; 8(1):214.
PMID: 39934243
PMC: 11814243.
DOI: 10.1038/s42003-025-07644-5.
Wozniak M, Czyz M
Ther Adv Med Oncol. 2025; 17():17588359241306026.
PMID: 39776536
PMC: 11705335.
DOI: 10.1177/17588359241306026.
Hong Z, Liu F, Zhang Z
Exp Hematol Oncol. 2024; 13(1):91.
PMID: 39223632
PMC: 11367865.
DOI: 10.1186/s40164-024-00552-0.
Gu Y, Yi Z, Zhou Z, Wang J, Li S, Zhu P
Nat Commun. 2024; 15(1):6730.
PMID: 39112443
PMC: 11306581.
DOI: 10.1038/s41467-024-50987-6.
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA).
Jasim S, Omar Dheyauldeen Salahdin , Malathi H, Sharma N, Rab S, Aminov Z
Cell Biochem Biophys. 2024; 82(4):3031-3051.
PMID: 39060914
DOI: 10.1007/s12013-024-01423-5.
Noncoding RNAs in tumorigenesis and tumor therapy.
Zhu P, Liu B, Fan Z
Fundam Res. 2024; 3(5):692-706.
PMID: 38933287
PMC: 11197782.
DOI: 10.1016/j.fmre.2023.05.014.
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y
J Hematol Oncol. 2024; 17(1):46.
PMID: 38886806
PMC: 11184729.
DOI: 10.1186/s13045-024-01563-4.
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Muliawan G, Lee T
Front Immunol. 2024; 15:1400112.
PMID: 38868769
PMC: 11167126.
DOI: 10.3389/fimmu.2024.1400112.
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine.
Younis M, Harashima H
Pharmgenomics Pers Med. 2024; 17:193-213.
PMID: 38737776
PMC: 11088404.
DOI: 10.2147/PGPM.S431346.
Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target.
Zhao Z, Cui T, Wei F, Zhou Z, Sun Y, Gao C
Front Oncol. 2024; 14:1367364.
PMID: 38634048
PMC: 11022604.
DOI: 10.3389/fonc.2024.1367364.
LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal.
Mouradian S, Cicciarello D, Lacoste N, Risson V, Berretta F, Le Grand F
Nucleic Acids Res. 2024; 52(7):3667-3681.
PMID: 38321961
PMC: 11040000.
DOI: 10.1093/nar/gkae060.
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
Zhao Q, Zong H, Zhu P, Su C, Tang W, Chen Z
Exp Hematol Oncol. 2024; 13(1):6.
PMID: 38254219
PMC: 10802076.
DOI: 10.1186/s40164-024-00474-x.
HCC-Related lncRNAs: Roles and Mechanisms.
Shah M, Sarkar D
Int J Mol Sci. 2024; 25(1).
PMID: 38203767
PMC: 10779127.
DOI: 10.3390/ijms25010597.
A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma.
Guo Z, Xie Y, Zhang L, Liu S, Jiang W
Aging (Albany NY). 2024; 16(1):267-284.
PMID: 38180745
PMC: 10817373.
DOI: 10.18632/aging.205367.
β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
Nakagawa C, Kadlera Nagaraj M, Hernandez J, Uthay Kumar D, Shukla V, Machida R
Front Immunol. 2023; 14:1204907.
PMID: 37744383
PMC: 10516572.
DOI: 10.3389/fimmu.2023.1204907.
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities.
Gajos-Michniewicz A, Czyz M
Genes Dis. 2023; 11(2):727-746.
PMID: 37692481
PMC: 10491942.
DOI: 10.1016/j.gendis.2023.02.050.
Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer.
Ghobashi A, Vuong T, Kimani J, Ladaika C, Hollenhorst P, OHagan H
iScience. 2023; 26(9):107630.
PMID: 37670785
PMC: 10475482.
DOI: 10.1016/j.isci.2023.107630.
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.
Wang C, Huang M, Lin Y, Zhang Y, Pan J, Jiang C
Nat Metab. 2023; 5(10):1765-1786.
PMID: 37667133
DOI: 10.1038/s42255-023-00883-y.
Methylation across the central dogma in health and diseases: new therapeutic strategies.
Liu R, Zhao E, Yu H, Yuan C, Abbas M, Cui H
Signal Transduct Target Ther. 2023; 8(1):310.
PMID: 37620312
PMC: 10449936.
DOI: 10.1038/s41392-023-01528-y.